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The human microbiota, i.e. the microbes living in or on humans, plays an important role 
in health and disease. Lifestyle factors, such as diet and physical activity as well as 
environmental factors, and exposure to antimicrobials (AMs) are likely among the 
important factors shaping the microbiota. Several studies have reported that the gut 
microbiota may be associated with overweight and obesity. Fewer studies have 
investigated associations between body mass index (BMI) and the salivary microbiota. 
There is a worldwide epidemic of obesity and the number of overweight and obese 
people reached 1.9 billion in 2016. Overweight and obese children are likely to stay 
obese into adulthood and tend to develop diseases more frequently and at a younger age. 
Thus, identification of the associations between microbiota and body size in young 
individuals are of great importance.   
The increased use of AMs rises concern of increasing antibiotic resistance resulting in 
lack of treatment options for many diseases. Exposure to AMs affects the microbial 
diversity and composition in the gut microbiota, but less is known about salivary 
microbiota. Since AM use is frequent in children, it is vital to study its associations with 
saliva microbiota at this age. The objectives of this doctoral thesis were to develop cost 
effective protocols to assess the salivary microbiota profiles for large-scale 
epidemiological studies and, with the new protocol, to determine its association with 
body size and lifetime antimicrobial use in children.  
In this thesis, all in-house 16S amplicon assays produced similar salivary microbiota 
profiles for the individual samples, i.e. there was no superior protocol. Salivary 
microbiota profiles of Finnish children were gender-specific in terms of alpha- and beta-
diversity and relative abundances of bacteria. A prominent finding was the decrease in 
the core bacteria in overweight and obese children. Lifetime AM exposure to saliva 
microbiota showed that Azithromycin use was associated with alpha-diversity in all 
children, and in girls. Microbiota dissimilarities were significant between children with 
low, medium and high number of AM user groups in all children with all AMs 
combined. Similar trend was significant with Azithromycin use, whereas Amoxicillin 
use affected the dissimilarity only in boys. 
This thesis suggests that the saliva microbiota is significantly associated with body size, 
antimicrobial use and gender in Finnish children. Thus, saliva microbiota profiles open 
new possibilities to study the potential roles of microbiota in weight development and 
management in children. In addition, the involuntary consequences of lifetime AM use 
are a concern and the importance of microbiota in the development of new therapeutic 
strategies should be emphasized in order to limit the use of AMs wisely.  Studies have 
shown that the saliva microbiota is more resilient and stable than gut microbiota when 
exposed to antibiotics. Thus, the saliva-based screening of microbial biomarkers in 
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health surveillance, and the associations with oral and general health status, may be 
considered feasible, simple, economical and easy to collect with high compliance for all 
age groups compared to faecal samples. However, further research on metabolic and 
functional potential of saliva microbiota is needed to fully understand the saliva 





Human microbiota research, i.e., studies of the microorganisms that live in or on humans 
and their role in health and disease, has gained significant interest in the last few years 
(Bai et al., 2018; Cho and Blaser, 2012; Gao et al., 2018; Hakansson et al., 2011; Thaiss, 
2018; Valdes et al., 2018; Wu et al., 2018). It has been proposed that gut microbes are 
the key to many aspects of human health, including immune (Zhang et al., 
2015b), metabolic (Rothschild et al., 2018) and neuro-behavioural traits (Levy et al., 
2017).  Recoveries from animal models (Fierer et al., 2008; Wiley et al., 2017) and 
human (Beaumont et al., 2016; Falony et al., 2016; Goodrich et al., 2014b; Sonnenburg 
and Sonnenburg, 2014) support the role of gut microbiota in health. Dysbiosis is broadly 
defined as any modification to the composition of resident commensal microbial 
communities relative to the microbial community found in healthy individuals (Petersen 
and Round, 2014). In the past decade, researchers have reported dysbiotic microbiota in 
human and animal models with inflammatory bowel diseases (IBD) (Frank et al., 2007), 
diabetes  (Karlsson et al., 2013), asthma  (Abrahamsson et al., 2014), allergies and even 
autism (Parracho et al., 2005) and many other diseases (Carding et al., 2015; Degruttola 
et al., 2016; Kho and Lal, 2018). Dysbiosis of the human gut microbiota may alter 
pathogenic mechanisms, which are associated with the development of obesity and 
insulin resistance (Musso et al., 2010) and with body size (Turnbaugh et al., 2006).  
Little is known about the salivary microbiota and body size, although the oral cavity 
possesses the second most diverse microbial community in the body (Kilian et al., 2016). 
The oral cavity is an open system and more exposed to the external environment, being 
the major gateway for microorganisms into the human body (Dewhirst et al., 2010). The 
oral cavity possesses around 600–700 common species, however, only around 68% of 
them have been cultivated using aerobic and anaerobic microbiological methods (Chen 
et al., 2010; Dewhirst et al., 2010). Lifestyle factors, such as diet, physical activity, 
environmental factors and socio-economic status are likely important factors shaping 
the oral microbiota and affecting the microbial composition of saliva  (Belstrom et al., 
2016; Li et al., 2014b). The salivary microbiota is more resilient than the faecal 
microbiota toward exposure to antibiotics (Zaura et al., 2015), and short-term 
hospitalization does not alter its composition (Cabral et al., 2017). The short-term 
ecological consequences of antibiotics on the gut microbiota are fairly well-established 
(Ferrer et al., 2017; Korpela et al., 2016), but less is known about effects of lifetime 
antimicrobial (AM) use on the salivary microbiota.  
The prevalence of obesity is increasing worldwide and the number of overweight and 
obese people reached 1.9 billion in 2016 (NCD Risk Factor Collaboration, 2017). Health 
consequences of obesity can be seen already in childhood and become more prevalent 
in adulthood (Turta and Rautava, 2016). Overweight and obese children are likely to 
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stay obese into adulthood and tend to develop diseases frequently and at a younger age. 
Moreover, with the increased use of antibiotics, we are currently facing the highest threat 
of antibiotic resistance worldwide (Leong et al., 2018). The human microbiota has a 
range of effects on the hosts physiological processes and behaviour (Festi et al., 2014; 
Jumpertz et al., 2011). Thus, investigating the associations between the microbiota and 
body size and antimicrobials in young individuals are of great importance. 
Microbiological studies using saliva rely on well-developed protocols, exploiting 
culture-independent next generation sequencing (NGS) technologies. A challenge using 
NGS is to ensure high reproducibility and repeatability of the method. The aims of the 
doctoral thesis were to develop an accurate methodology to assess the salivary 
microbiota profiles for large-scale epidemiological studies and, with the new method, to 




2. REVIEW OF LITERATURE 
2.1 Human microbiome 
The human microbiome likely plays an important role in health and well-being. The 
term microbiome was coined in 2001 and defined as "ecological community of 
commensal, symbiotic and pathogenic microorganisms” which include archaea, 
bacteria, viruses, and microscopic eukaryotes, including fungi (Lederberg and McCray, 
2001; Peterson et al., 2009). Collectively, all these microbes can be referred to as 
microbiota, while a group of these organisms and their environments such as the cells, 
genomes and metabolites of the host are referred to as microbiome (Whiteside et al., 
2015; Young, 2017). Human microbiota research has been focusing on bacteria due to 
their clinical significance and the technical challenges to characterise microbes other 
than bacteria. It has been estimated that microbial cells in the human body (human 
microbiome) outnumber human cells by a factor of 10 or more (Bäckhed et al., 2005), 
but the recent estimate suggests that the ratio of human cells to microbial cells is 
approximately 1:1.3 (Sender et al., 2016). Individual body habitats typically harbour 
dozens of bacterial phyla and hundreds of bacterial phylotypes. Phylotype defined as 
observed similarity used to classify a DNA sequence or group of sequences by their 
evolutionary relationship (Moreira and López-García, 2014). The number of bacteria 
may differ dramatically between individuals, across body habitats, and within an 
individual body habitat over time; however, the majority of body habitats are dominated 
by just a few bacterial phyla (Fierer et al., 2012) (Figure 1). Humans are not an 
autonomous organism; together with microbiome we form a ‘superorganism’ or 
holobiont with microbial community playing a significant role in human physiology and 
health (Bordenstein and Theis, 2015) (Figure 2). The mutually beneficial relationship 
between the host and microbiota has provided essential contributions to human health 
e.g. by producing metabolites and vitamins and in return are allowed to occupy a nutrient 
rich environment (Salonen and de Vos, 2014). The microbiota is also beneficial in the 
maturation of the human immune system (Nylund et al., 2014). Among all the human 
microbiome from different body habitats, the gut microbiota is the most studied and 
focused upon by researchers; there were nearly 12,900 articles published on this topic 
between the years 2012 to 2017 (Cani, 2018). Since invasive procedures required to 
collect samples from the gastrointestinal (GI) tract, most of the studies use stool samples 
to get an overview of the gut microbiota (Cani, 2018). It comprises of bacteria, archaea, 
eukaryotes and viruses, and 1000 bacterial species in the gut are dominated by the two 
phyla, Firmicutes and Bacteroidetes (Figure 1) (Eckburg et al., 2005). This microbial 
community with millions of genes provides wide range of additional metabolic potential 







Figure 1: Composition of dominant bacterial phyla in various body habitats. Figure modified from 





Figure 2: The positive effects of the microbiome on human. Figure modified from Kilian et al., 2016 
Unlike the human genome, the gut microbiome can be vertically transmitted and fixed; 
it can also be modified by early life events, diet and exposure to antibiotics affecting the 
composition, stability and function of the gut ecosystem. At the lower level of genera 
and species, the bacterial composition of the microbiota shows inter-individual 
variation, i.e. each individual possesses a unique microbial fingerprint. The microbial 
fingerprint is stable over time and resilient, but not to perturbations like antibiotic 
exposure (Leong et al., 2018).  
2.1.1 Oral microbiota 
The oral cavity is highly exposed to the environment and is the major gateway for 
microorganisms into the human body. Microorganisms enter the body through food and 
air, and are then either mixed with saliva on the way to the intestinal tract, or left behind 
to colonize the oral cavity (Dewhirst et al., 2010). The oral cavity comprises several 
distinct microbial habitats, such as teeth, gingival sulcus, attached gingiva, tongue, 
cheek, lip, hard palate, and soft palate. The human oral microbiome defined as all the 
microorganisms that are present on or in the human oral cavity and its contiguous 
extensions (such as tonsils, pharynx, esophagus, Eustachian tube, middle ear, trachea, 
lungs, nasal passages, and sinuses) (Dewhirst et al., 2010). Different oral habitats and 
tissues are colonized by distinct microbial communities (Aas et al., 2005; Mager et al., 


























biofilms. Oral biofilms, a unique survival strategy of microbes, are present on all intra-
oral surfaces. Biofilm helps microbes to adapt to environmental change by altering their 
gene expression patterns which can protect the microbes from disinfectant agents or 
antibiotics (Berger et al., 2018). A balanced oral microbiome assist in maintaining oral 
health and symbiosis. Dysfunction of salivary gland often disturbs the oral microbiome 
which leads to oral and systemic diseases associated with it (Lynge Pedersen and 
Belstrøm, 2019).  
2.1.2 Saliva microbiota 
The microorganisms in the human saliva (the saliva microbiome) have been associated 
with diseases of both the oral cavity and general health (Krishnan et al., 2017). Bacteria 
in the saliva are especially shed from adhering microbial communities on various 
intraoral surfaces, including tooth surfaces, gingival crevices, tongue dorsum, and 
buccal mucosa (Takeshita et al., 2016). Saliva microbiota profiles enable the detection 
of various oral infectious diseases and upper respiratory infections (Wong, 2012). The 
salivary microbiota is more resilient than the gut microbiota toward exposure to 
antibiotics, irrespective of antibiotics taken (Zaura et al., 2015), and to short-term 
hospitalization (Cabral et al., 2017). The saliva microbiota remains highly stable over 
several years, even when changes in diet and oral hygiene may occur (Stahringer et al., 
2012). Microbes in the oral cavity are the etiological agents for a number of infectious 
diseases such as caries, periodontitis, endodontic infections, alveolar osteitis and 
tonsillitis (Duran-Pinedo and Frias-Lopez, 2015).  
2.1.3 Saliva as a diagnostic bio-fluid 
Saliva is an aqueous, transparent biological fluid containing a complex mixture 
produced by secretions from the salivary glands, combined with bacteria of the oral 
cavity, desquamated cells and food debris (Humphrey and Williamson, 2001; Nieuw 
Amerongen and Veerman, 2002; Pappa et al., 2019). Saliva is generated by acinus cells 
within the salivary glands and released into the oral cavity via small ducts (Tiwari, 2011; 
Yoshizawa et al., 2013). Saliva plays a key role in keeping a ‘healthy mouth’. Evidently, 
a reduction in saliva flow increases the risk of dental caries. It lubricates the oral surfaces 
and helps in reducing demineralization of damaging acids from biofilms, clearing food 
and promoting remineralization (Marsh et al., 2016). Saliva is an ideal diagnostic fluid 
useful for studies in vulnerable patient populations such as neonates and children as it 
is an easy, simple, painless and non-invasive method for sampling (Figure 3 ) (Ranger 
and Grunau, 2014; Schafer et al., 2014). Saliva harbors wide range of structurally and 
functionally complex host molecules (proteins and glycoproteins) which are primary 
nutrients for the resident microbiota (Marsh et al., 2016). Saliva is rich in  biomarkers 
for oral and systemic disorders, such as antibodies, DNA, RNA, metabolites, cytokines, 
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enzymes and hormones like cortisol (Giannobile et al., 2011; Kononen et al., 2007; 
Yoshizawa et al., 2013).  
 
Figure 3: Applications of the saliva as a diagnostic fluid in paediatrics. Figure modified from Pappa et 
al., 2019. 
2.2 Microbiota profiling 
Interest in studying associations of the human microbiota with human health status using 
the 16S rRNA gene, a phylogenetically informative housekeeping genetic marker, has 
rapidly increased (Lane et al., 1985; Tringe and Hugenholtz, 2008; Zheng et al., 2015). 
Taxonomic investigation in microbiota studies is based on amplification of 
hypervariable regions of the 16S rRNA gene sequences for several reasons: the 16S 
rRNA gene is present in all archaea and bacteria, it has both conserved and species-
specific variable regions, it is extensively studied and comprehensive databases 
(SILVA, RDP and Greengenes) exist (Tseng et al., 2013). Cultivation-independent 
molecular methods have validated different estimates and identified approximately 600 
species or phylotypes in the oral cavity using 16S rRNA gene sequencing techniques 
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(Dewhirst et al., 2010; Paster et al., 2001). Precise microbiota profiling depends heavily 
on the hypervariable region of the 16S rRNA gene selected and primers used, and the 
amplification of non-representative genomic regions may lead to taxonomic resolution 
bias (Wen et al., 2017; Zheng et al., 2015). Development of next generation sequencing 
(NGS) technologies and the application of barcode indexing help to sequence a large 
number of samples simultaneously (Andersson et al., 2008; de Muinck et al., 2017; 
Hamady et al., 2008). However, reproducibility and repeatability of the microbiota 
profiling remain challenging (Ding and Schloss, 2014). The 16S rRNA V3-V4 
hypervariable region is widely used in various microbiota studies, although other 
hypervariable regions have also been used (Belstrøm et al., 2016; Fadrosh et al., 2014; 
Janem et al., 2017; Zheng et al., 2015).  Introduction of dual indexing and its application 
to the sequencing protocols helped to yield a greater utilization of available sequencing 
capacity (Kozich et al., 2013). Recent advancements and reduced prices have directed 
researchers to use the latest technologies while abandoning the old ones; however, the 
evaluation of new methodology is crucial and should be performed before conducting 
microbiome studies (Sinclair et al., 2015).  
2.3 Microbiota and obesity 
2.3.1 Obesity 
Obesity is “condition of abnormal or excessive fat accumulation in adipose tissue, to the 
extent that health may be impaired” (World Health Organization, 2000). There is a 
worldwide epidemic of obesity and the number of overweight and obese people globally 
has almost tripled since 1975 (World Health Organization, 2018). In 2016, 1.9 billion 
(39%) of adults aged 18 years and above were overweight, and 650 million (13%) of 
these were obese (World Health Organization, 2018). A measure of obesity is the body 
mass index (BMI), a person’s weight (in kilograms) divided by the square of his or her 
height (in metres). For adolescents under 18 years of age, BMI cut-offs used are age- 
and gender-specific (Cole and Lobstein, 2012).  
The mechanism behind the obesity believed to be disorder with multiple causes, i.e: 
genetics, environmental factors, life styles and socio-cultural factors (Figure 4). In 
general, overweight and obesity are identified to be the results of increased calorie and 




Figure 4: Causes of childhood obesity. Figure modified from Sahoo et al., 2015.  
 
Figure 5: Consequences of childhood obesity. Figure modified from Ebbeling et al., 2002. 
According to the World Health Organization, around 340 million children and 
adolescents aged 5-19 years were overweight or obese. Overweight and obese children 
are likely to stay obese into adulthood (Juonala et al., 2019; Turta and Rautava, 2016; 
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Woo et al., 2019), unless remedial measures are taken to tackle it, and they are inclined 
to develop diseases more frequently and at a younger age than normal weight children. 
The health consequences of obesity (Figure 5), which include type 2 diabetes mellitus, 
non-alcoholic fatty liver disease, and ischemic cardiovascular disease may be initiated 
already in childhood and become more prevalent in adulthood (Despres and Lemieux, 
2006; Turta and Rautava, 2016). Other health consequences are related to neurological 
(Balcer et al., 1999), cardiovascular (Ford et al., 2001; Srinivasan et al., 2002; Tounian 
et al., 2001), endocrine (Ebbeling et al., 2002; Kaplowitz et al., 2001; Lewy et al., 2001), 
musculoskeletal (Dowling et al., 2001; Goulding et al., 2001; Loder and Skopelja, 
2011), renal (Adelman et al., 2001), gastrointestinal (Friesen and Roberts, 1989; Strauss 
et al., 2000), pulmonary diseases (Figueroa-Muñoz et al., 2001; Redline et al., 1999; 
Reybrouck et al., 1997) and psychosocial consequences (Balcer et al., 1999; Davison 
and Birch, 2001; Erickson et al., 2000; Field et al., 1999; Strauss, 2000). In addition, 
obesity is associated with lower life expectancy, poor quality of life, work disability and 
healthcare costs (Collaboration et al., 2016; Fontaine and Barofsky, 2001; van 
Duijvenbode et al., 2009). The prevalence of obesity in adults has extensively increased 
during 1978-2017 in Finland (Borodulin et al., 2018). Nowadays every fourth man and 
woman is obese in Finland. Also, the prevalence of severe obesity has increased and, 
one of 20 men and one of 10 women are severely obese. If the current scenario continues 
in Finland, every third adult is expected to be obese by 2028 (Borodulin et al., 2018).  
The prevalence of overweight and obesity in children and adolescents is also increasing 
globally, with a threefold increase in Finland (NCD Risk Factor Collaboration, 2017). 
According to the International Obesity Task Force (IOTF) using BMI cut-off values for 
adolescents (Cole and Lobstein, 2012), 19% of 2-16-year-old Finnish children and 
adolescents were classified as overweight, and 5% of boys and 4% of girls as obese in 
2014–2015 (Mäki et al., 2017). According to a recent report from the National Institute 
for Health and Welfare (THL) based on outpatient health care register data (AvoHilmo), 
21% of girls and 38% of boys aged 7-12 years were overweight or obese (Lundqvist and 
Jääskeläinen, 2019).  
2.3.2 Gut microbiota and obesity 
Associations between the gut microbiota and obesity have been shown in both animal 
models and humans (Parekh et al., 2015; Sze and Schloss, 2016). For example, the ratio 
of  Firmicutes to Bacteroidetes (F/B ratio) was lower in obese mice than in lean mice 
(Ley et al., 2005).  Human studies have shown that obese individuals had lower alpha-
diversity than lean individuals (Turnbaugh et al., 2009) and that obesity in adults and 
children is associated with different profiles of gut microbiota (Castaner et al., 2018; 
Goodrich et al., 2014a, 2014b; Hu et al., 2015; Ley et al., 2006; Nakayama et al., 2015; 
Turnbaugh et al., 2009). A recent study reported a higher abundance of family 
Tissierellaceae and genus Blautia, and lower abundance of Methanobrevibacter in the 
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gut microbiota of obese vs. normal weight adults (Org et al., 2017). From the limited 
research focused on obesity in children and adolescents and their gut microbiota;  
Bacteroides and Prevotella were significantly associated with the adolescent BMI (Hu 
et al., 2015), abundance of nine bacteria was associated with overweight and obesity in 
Mexican children (Murugesan et al., 2015) and an altered gut microbiota characterized 
by high abundance of Firmicutes and lower Bacteroidetes was associated with obesity 
(Riva et al., 2017). Bacterial dysbiosis (imbalance) has been linked to the development 
of obesity, either through direct effect on the gut or indirect regulation on distal organs 
and systems (Clarke et al., 2014; Leong et al., 2018).   
Intestinal bacteria are capable of breaking down the indigestible polysaccharides (fibre) 
and resistant starch to short chain fatty acids (SCFA) to provide 80-200 kcal/d energy, 
and  dysbiosis may alter the energy harvest in the gut (Jumpertz et al., 2011). SCFAs 
also modulate the production of gut hormones which directly influence satiety (Festi et 
al., 2014). Intestinal bacteria have a key role in bile acid metabolism that can have a 
strong effect on host energy metabolism. Dysbiosis may fail to de-conjugate toxic 
primary bile acids produced by the host, by bacterial bile-salt hydrolases, leading to 
reduced numbers of Lactobacilli and Bifidobacteria considered protective against 
obesity (Kurdi et al., 2006).  
2.3.3 Saliva microbiota and obesity 
Oral bacteria have been associated with a number of oral (Gao et al., 2018), non-oral 
and systemic diseases (He et al., 2015; Krishnan et al., 2017) and cancer (Mager et al., 
2005) (Table 1). Dysbiosis in the gut microbiome is associated with obesity and its co-
morbidities (Turnbaugh et al., 2006), however, little attention has been paid to saliva 
microbiota and obesity. Goodson et al first postulated the association of the oral 
microbiota with obesity in 2009 (Goodson et al., 2009).  
 
Table 1:  Summary of findings from studies on salivary microbiota with non-oral diseases. Table adapted from (Acharya et al., 2017a). 
Diseases References Key findings (in disease) 
Auto-immune diseases 
Celiac disease Tian et al., 2017 High abundance- Lactobacilli (both in refractory and treated celiac disease cases) 
Celiac disease  Siragusa et al., 2014 High abundance - Lachnospiraceae, Gemellaceae, Streptococcus sanguinis, Porphyromonas sp., 
Prevotella nanceiensis, Rothia, SR1,  
Low abundance-  Bacilli, Selenomonas and Actinomyces oris  
Lower alpha-diversity (richness)  
Sjögren's syndrome  Sandhya et al., 2015 High abundance - Capnocytophaga, Dialister, Fusobacterium, Helicobacter, Streptococcus, 
Veillonella spp. and lower Pseudomonas spp. 
Sjögren's syndrome  Li et al., 2016 Low abundance-  Proteobacteria  
Lower alpha-diversity (richness)  
Behçet's disease  Coit et al., 2016 High abundance -  Haemophilus parainfluenzae  
Low abundance - Alloprevotella rava and Leptotrichia  
Behçet's disease  Seoudi et al., 2015 High abundance - Bifidobacterium dentium, Prevotella histicola  
Low abundance - Campylobacter concisus, Clostridiales spp., Fusobacterium periodonticum, 
Gemella sanguinis, Neisseria spp., and Oribacterium sinus levels in disease 
Rheumatoid arthritis  Zhang et al., 2015c, 2015a High abundance - Lactobacillus salivarius levels  
Low abundance -  Haemophilus spp.  
Inflammatory bowel 
disease  
Said et al., 2014 High abundance of Bacteroidetes and  
Low abundance - Proteobacteria,  
salivary immunological biomarkers correlated significantly with several dominant genera e.g.; 
Prevotella with interleukin-1 beta 
Immunoglobulin A 
nephropathy  
Piccolo et al., 2015 Low abundance - Firmicutes to Proteobacteria ratio,  
Health-associated taxa - Gemella haemolysans, Granulicatella adiacens, Veillonella parvula and 
many Prevotella spp. 
Cancer 
Pancreatic cancer  Fan et al., 2018 High abundance - Porphyromonas gingivalis, Aggregatibacter actinomycetemcomitans associated 
positively  
Fusobacteria, Leptotrichia associated negatively with pancreatic cancer risk. 
Pancreatic cancer  Torres et al., 2015 High abundance - Leptotrichia to Porphyromonas ratio  
Low abundance - Neisseria and Aggregatibacter 
Pancreatic cancer and 
chronic pancreatitis  
Farrell et al., 2012 High abundance of Granulicatella adiacens, 
Low abundance - Neisseria elongata, and Streptococcus mitis 
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Esophageal cancer  Chen et al., 2015 High abundance -  Prevotella, Streptococcus and Porphyromonas,  
Low abundance - Lautropia, Bulleidia, Catonella, Corynebacterium, Moryella, Peptococcus, 
Cardiobacterium  
Lower alpha-diversity  
Nasopharyngeal carcinoma  Xu et al., 2014 High abundance – Firmicutes, Neisseria, Leptotrichia, Pseudomonas 
Low abundance - Proteobacteria, Streptococcus 
Colorectal cancer Flemer et al., 2018 Differentially abundant in CRC -  Streptococcus and Prevotella 
Genetic disorders 
Fanconi’s anemia & history 
of transplant  
Furquim et al., 2017 High abundance - Firmicutes, Veillonella, Streptococcus, Haemophilus in patients with graft 
versus host disease.  
Higher Streptococcus, Haemophilus, Aggregatibacter, Selenomonas, Capnocytophaga, 
Corynebacterium with severe oral mucositis 
Cystic fibrosis (pediatric)  Zemanick et al., 2015 Lower alpha-diversity & greater divergence in composition from Lower airway microbiome (beta-
diversity) was associated. 
Parkinson's disease (PD) Pereira et al., 2017 PD patients and control subjects had differences in beta-diversity  
Differences in abundances of individual bacterial taxa 
Immunodeficiency states 
HIV  Noguera-Julian et al., 2017 High abundance - Neisseria in HIV-positive and 
High abundance - Treponema in HIV-positive with severe periodontal disease. 
HIV-AIDS  Zhang et al., 2015a, 2015c High abundance - Porphyromonas, Treponema, Eubacterium in AIDS patients with periodontitis.  
HIV (well-controlled)  Kistler et al., 2015 Haemophilus parainfluenzae associated positively & Streptococcus mitis (HOT473) negatively 
with disease, no major differences in community composition with disease. Haemophilus 
parainfluenzae, Actinomyces positively associated and Alloprevotella tannerae, Eubacterium yurii 
negatively associated with CD4 cell counts 
HIV (well-controlled, 
pediatric)  
Goldberg et al., 2015 No significant differences in community configuration (beta-diversity) or alpha-diversity between 
disease and health 
HIV (before and after 
Highly active retroviral 
therapy) 
Li et al., 2014c High abundance - Bacteroidetes,  
Low abundance - Actinobacteria, Fusobacteria , Fusobacterium, Campylobacter, Leptotrichia  
Lower alpha-diversity with disease. 
Transplant associated 
immunosuppression  
Diaz et al., 2013 High abundance - Gammaproteobacteria; Klebsiella pneumoniae, Pseudomonas flurosccns, 




Schuurhuis et al., 2016 High abundance of opportunistic species; enteric rods, Staphylococcus, Candida after radiation 
therapy (with and without chemotherapy both) 21
 
Metabolic disorders 
High interleukin-1 beta 
levels  
Acharya et al., 2017b Beta-diversity & Prevotella to Bacteroides ratio, associated with interleukin-1 beta levels. 
High abundance - Proteobacteria spp, Aggregatibacter, Halomonas, Propionivibrio, Paracoccus, 
Mannhemia, Anaerobacillus, Micrococcus, Bradyrhizobiaceae, Caulobacteraceae were indicators 
of high interleukin-1 beta. 
Diabetes mellitus-Type 2 & 
Obesity (pediatric) 
Janem et al., 2017 Diabetes mellitus showed lower levels of Lautropia, Cardiobacterium, Corynebacterium 
Diabetes mellitus-Type 2  Kampoo et al., 2014 High abundance - Streptococcus spp., Lactobacillus spp. associated with high caries incidence in 
diabetics 
High salivary glucose 
levels  
Goodson et al., 2017 High abundance - Firmicutes, Parvimonas micra,  
Low abundance - Bacteroidetes, Prevotella spp. predicted high salivary glucose. 
Stroke  Boaden et al., 2017 No association of salivary microbiota configuration and oral health status  
Polycystic ovary syndrome  Lindheim et al., 2016 Low abundance – Actinobacteria 
Atherosclerosis  Fåk et al., 2015 High abundance - Parvimonas, Capnocytophaga, Catonella, Lactobacillus associated with serum 
biomarkers. 
Hepatic encephalopathy  Bajaj et al., 2015 High abundance - opportunistic taxa, Prevotellaceae, Fusobacteriaceae and Enterococcaceae, 
Enterobacteriaceae,  
Low abundance - resident taxa, Erysipelothricaceae in disease.  
Enterobacteriaceae correlated negatively with antiinflammatory cytokine Interleukin-10. 
Other 
Antibiotic treated Low birth 
weight neonate 
Costello et al., 2013 High abundance - Pseudomonas aeruginosa, Ureaplasma parvum, a novel Mycoplasma sp. were 




The reports on the association of the oral microbiome with obesity are inconsistent. In a 
study including 87 adolescents, a six-fold increase of Campylobacter rectus and 
Neisseria mucosa was found in subgingival biofilms of obese subjects in comparison 
with lean (Zeigler et al., 2012).  According to an Italian study including 28 obese and 
28 normal weight adults Firmicutes and Actinobacteria were more abundant in saliva 
microbiota of obese individuals, while Proteobacteria and Fusobacteria dominated in 
normal weight individuals (Piombino et al., 2014). In contrast, a Danish study including 
292 adults failed to show an association between BMI and saliva microbiota (Belstrøm 
et al., 2014). A periodontal pathogen Tannerella forsythia has been reported to be 
positively correlated with BMI in periodontally healthy adults (Haffajee and Socransky, 
2009; Stahringer et al., 2012). In a recent Japanese study focusing on saliva microbiome, 
a higher phylogenetic diversity was observed in individuals with obesity; however, the 
effects of periodontal disease might have confounded the results (Takeshita et al., 2016). 
A recent study showed that obesity was associated with the saliva microbiota 
composition (Tam et al., 2018).   
2.4 Microbiota and antimicrobials (AMs) 
2.4.1 Use of antimicrobials 
Antimicrobials, hailed as a ‘miracle drug’, have revolutionized the field of medicine 
because  they effectively treat infectious bacterial diseases (Zaffiri et al., 2012). AMs 
are a group of agents that share the common aim of reducing the growth or killing 
microorganism. AMs are made synthetically or from moulds, and are absorbed into the 
body to kill the bacteria (bactericidal) or to prevent the bacterial multiplication 
(bacteriostatic) (Nankervis et al., 2016). AMs are the most commonly used drugs in 
paediatric patients and have helped to reduce the morbidity and mortality associated 
with bacterial infections in children (Principi and Esposito, 2016; Zhang et al., 2013). 
However, the increased use of AMs can cause unwanted problems such as development 
of AM resistance and AM-induced gut microbiota dysbiosis (Principi and Esposito, 
2016). Paediatric populations are more prone to use AM, in 2011, 40% of children under 
16-year-old have used antibiotics at least once in Finland (Virta, 2012). 
2.4.2 Gut microbiota and antimicrobials 
Exposure to AMs has a high impact on all microbiomes compared to other 
environmental factors (Modi et al., 2014). The gut microbiota in adults is strongly 
affected by AMs administration, and it is non-resilient to repeated AM use 
(Dethlefsen and Relman, 2011). The short-term ecological consequences of AMs on 
the gut microbiota are fairly well-established (Ferrer et al., 2017; Korpela et al., 2016), 
but less is known about the effects of lifetime AM use on saliva microbiota. Amoxicillin 
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is a commonly used drug and prescribed in dentistry for chemoprophylaxis of infective 
endocarditis; and in a study of 4 to 5-year-old children, amoxicillin-resistant oral 
bacteria have been observed (Lazarevic et al., 2013b; Ready et al., 2004). The use of 
AM including amoxicillin, erythromycin, josamycin and tetracycline can increase the 
number of antibiotic-resistant bacteria in the oral cavity (Harrison et al., 1985; Ready, 
2002; Ready et al., 2004; Sefton, 1999; Woodman et al., 1985). The effect of a 6-week 
intravenous AM therapy in humans found significant changes in oral and faecal bacterial 
communities (Abeles et al., 2015). The gut microbiota is prone to large shifts in the 
diversity and composition with several perturbations like diet, exercise and 
antimicrobials (Cabral et al., 2017). The instability of the gut microbiota due to the 
antimicrobial exposure could make it difficult in drawing the conclusion of microbiome 
shifts and their relevance to human health in clinical settings (Cabral et al., 2017). AM 
agent clindamycin cause dysbiosis higher than ciprofloxacin in gut (Rashid et al., 2015), 
and it takes 1 to 12 months to normalise the microbiota (Francino, 2016). 
2.4.3 Salivary microbiota and antimicrobials 
Salivary microbiota seems to be consistent between individuals and is considerably less 
diverse in comparison to the gut microbiota (Zaura et al., 2015). A study that compared 
the salivary and faecal microbiota after AM use demonstrated that saliva microbiota is 
more resilient than the gut microbiota (Zaura et al., 2015). A single dose of 2g 
amoxicillin can cause dysbiosis in oral cavity and induce selection of resistant strains, 
genus Streptococci with reduced susceptibility to amoxicillin was significantly 
increased (Chardin et al., 2009; Khalil et al., 2016). The prevalence of penicillin-
resistant Fusobacterium nucleatum in infants has been shown (Nyfors et al., 2003), due 
-lactamase  producing species with the use of antimicrobial agents during 
the first year of life (Nyfors et al., 1999). The effect of single AM dose and short-term 
AM therapy on saliva microbiota in adults have been shown, where single dose of most 
commonly used AMs causes minor and short-term changes in saliva microbiota (Abeles 
et al., 2015; Lazarevic et al., 2012; Zaura et al., 2015). The saliva microbiota of adults 
treated with azithromycin fully regained its original status within eight weeks, while the 
effects were longer lasting in the gut (Abeles et al., 2016). Thus using saliva microbiota, 
which shows more temporal stability, may help to understand different long-term 





3. AIMS OF THE DOCTORAL THESIS 
The objectives of this thesis were to develop cost effective protocols to characterize 
saliva microbiota profiles and to study the association of the saliva microbiota with body 
size, and lifetime antimicrobial use in children. The specific aims of the studies in this 
thesis were: 
1. To identify the reproducibility and repeatability of the saliva microbiota profiles 
produced with simplified in-house 16S amplicon assays by comparing triplicate 
samples (I).  
2. To discover the association between the saliva microbiota and body size in a 
large-scale study of Finnish children (II).  
3. To discover the association between lifetime antimicrobial use and the saliva 




4. MATERIALS AND METHODS 
4.1 Ethical aspects 
The Coordinating Ethics Committee of the Hospital District of Helsinki and Uusimaa 
has approved the Fin-HIT study protocol (169/13/03/00/10). Participants and one of 
their parents have given written informed consent, which allows us to integrate the 
national health register data as a part of the research material (Figure 7). Participants 
had right to withdraw their consent whenever they wish to. 
4.2 Study population 
All the subjects included in the studies II and III were from the “The Finnish Health in 
Teens study — Fin-HIT —  cohort (Table 2 and 3), which includes approximately 
11,000 Finnish children in the age 9-14 years and their legal guardians (Figueiredo et 
al., 2018). The cohort participants were from densely populated regions of Finland, i.e; 
Uusimaa, Varsinais-Suomi, Häme, Pirkanmaa, Keski-Suomi, Pohjois-Savo and 
Pohjois-Pohjanmaa regions. Geographically, a large part of Finland was represented in 
the study, including 44 municipalities and some of Finland’s largest cities: Helsinki, 
Turku, Espoo, Oulu, Jyväskylä, Tampere and Kuopio. Recruitment of participants and 
baseline data collection was performed during 2011-2014 (Figure 7). 
 




Table 2: Characteristics of children included in study II 
Body sizes Boys Girls Total 
Underweight 48 77 125 
Normal weight  307 353 660 
Overweight 52 44 96 
Obese 10 9 19 
Total 417 483 900 




11 227 27.1 
12 610 72.9 
Gender  
Boy 388 46.4 
Girl 449 53.6 
Language  
Finnish 711 84.9 
Swedish 89 10.6 
Other 37 4.4 
 
4.2.1 Saliva samples 
Saliva samples in triplicates from four volunteers were collected for study I (Figure 6). 
The saliva (unstimulated) samples were collected in Oragene-DNA (OG-500) self-
collection kits (DNA Genotek Inc., Canada) (I, II & III). The samples were mixed with 
a stabilizing reagent within the collection tubes per manufacturer’s instructions by 




Figure 8: Saliva collection instruction from the Oragene-DNA (OG-500) self-collection kits (DNA 
Genotek Inc., Canada). https://www.dnagenotek.com/ROW/support/collection-instructions/oragene-
dna/OG-500andOG-600.html 
4.2.2 BMI groups/ Body size 
The fieldworkers followed a standardized protocol to measure anthropometric 
measures: height, weight and waist circumference for all children. BMI was calculated 
as weight (kg)/height (m)2 and the children were classified as underweight, normal 
weight, overweight or obese (BMI categories) according to age- and sex-specific cut-
offs suggested by International Obesity Task Force (IOTF) (Cole and Lobstein, 2012). 
BMI categories were used in the study II. 
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4.3 Cohort data collection 
4.3.1 Demographics/questionnaire data 
During the cohort data collection, the participants filled in self-administered web 
questionnaire on lifestyle factors, mental health, adolescent growth environment, 
provided a saliva sample, and had their anthropometric measures measured in a 
standardized way at school (Figueiredo et al., 2018; Sarkkola et al., 2016). Information 
on subjects’ lifestyle and health behaviour included diet, meal patterns, physical activity, 
parents’ attitudes toward physical exercise, screen time, TV-programmes watched, 
bullying, and sleep patterns.  
4.3.2 Register data 
Additional information on the participants was obtained from the national health 
registers: (a) the Population Information System at the Population Register Centre 
(https://eevertti.vrk.fi/etusivu), which contains information on home address and mother 
tongue; (b) the Social Insurance Institution of Finland, (http://www.kela.fi/), which 
includes information on medical prescriptions, purchases of prescribed drugs and patient 
spending on these drugs; and (c) Statistics Finland  providing information on 
occupational status, wages and cause of death and (d) the National Institute for Health 
and Welfare (THL) providing information of Medical Birth Register, the Care Register 
for Health Care and the Register of Primary Health Care Visits, and information on 
diseases, pregnancy, new-born health, diagnoses, etc. (Figueiredo et al., 2018).  
4.3.3 Medical prescription/reimbursement data  
In Finland, all the antimicrobial (AM) agents for systemic use are available by 
prescription and sold solely in registered pharmacies. The Drug Prescription Register 
held by the Social Insurance Institution of Finland (KELA, www.kela.fi) register drug 
purchases based on prescriptions. Information on drug purchase dates and 
pharmaceuticals of Fin-HIT cohort participants were linked to the study database. 
Information on all systemic antimicrobials were extracted. The information on 
antimicrobials administered in hospitals were not collected. The purchases of 
antimicrobials is considered to reflect the use of AM of interested for the study. In study 
III, the AM prescriptions used from birth to participation date were restricted in the 
analysis (Table 3). Among all the AMs; Amoxicillin (ATC-code: J01CA04), 
Azithromycin (J01FA10), Amoxicillin + enzyme inhibitor (J01CR02) and 




4.4 Molecular biology methods 
4.4.1 16S rRNA sequencing 
All of the studies in this thesis followed the same DNA extraction protocol. A protocol 
with an intensive lysis step combining the mechanical and chemical lysis using a 
cocktail of lysozyme and mechanical disruption of microbial cells using bead-beating 
was employed. Fifty ml lysozyme (10 mg/ml, Sigma-Aldrich), 6 ml mutanolysin (25 
KU/ml, Sigma-Aldrich), and 3 ml lysostaphin (4000 U/ml, Sigma-Aldrich) were added 
to a 500 μl aliquot of cell suspension followed by incubation at 37 ºC for 1 h. 
Subsequently, 600 mg of 0.1 mm-diameter zirconia/silica beads (BioSpec, Bartlesville, 
OK) were added to the lysate and the microbial cells were mechanically disrupted using 
Mini-BeadBeater-96 (BioSpec, Bartlesville, OK) at 2100 rpm for 1 min (Yuan et al., 
2012). After lysis, total DNA was extracted using cmg-1035 saliva kit, and Chemagic 
MSM1 nucleic acid extraction robot (PerkinElmer). Lysis step helps to disintegrate the 
microbial cells. The desired region of the 16S rRNA gene, the V3-V4 region was 
amplified using Polymerase chain reaction (PCR). 
4.4.2 PCR amplification 
PCR amplification and sequencing libraries were prepared according to in-house 16S 
rRNA gene-based PCR amplification protocols. All protocols used 16S primers (S-D-
Bact-0341-b-S-17: 5’ CCTACGGGNGGCWGCAG ’3 and S-D-Bact-0785-a-A-21: 5’ 
GACTACHVGGGTATCTAATCC 3’) targeting the V3-V4 region as reported 
previously (Klindworth et al., 2013). In the study I, the 16S primers were modified by 
adding the Illumina Truseq (TS) and Nextera (NX) adapter sequences to the 5’-ends. 
Amplification was done using primers with and without incorporated internal index 
(denoted as ii). Two sets of index primers carrying Illumina grafting P5/P7 sequence 
were used: in-house index primers with Truseq adapter sequence and Illumina Nextera 
i5/i7 adapters. All oligonucleotides (except Illumina Nextera i5/i7 adapters) were 
synthesized by Sigma-Aldrich (St. Louis, MO, USA). Barcodes used to sequence large 
set samples in one pool, which is economic. 
4.4.2.1 TS-tailed 1-step amplification 
TS-tailed 1-step PCR amplification was employed in a part of study I and all of the 
studies II & III. Amplification was performed with 16S rRNA gene-based primer 
carrying Truseq adapter and Truseq index primer. Separate reactions were done using 
16S rRNA gene-based primers with and without incorporated 6-base internal index. 
Here after this protocol denoted as TS-tailed-1S. 
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4.4.2.2 TS-tailed 2-step amplification  
TS-tailed 2-step amplification protocol was employed only in a part of the study I. 
Amplification was performed with 16S rRNA gene-based primer carrying Truseq 
adapter. Separate reactions were done using 16S rRNA gene-based primers with and 
without incorporated internal index. Following PCR amplification, samples were 
purified and an additional PCR step was employed to add index sequences to the PCR 
product. Here after this protocol denoted as TS-tailed-2S. 
4.4.2.3 NX-tailed 2-step amplification  
NX-tailed 2-step amplification protocol was employed only in a part of the study I. 
Amplification was performed with 16S rRNA gene-based primers carrying Nextera 
adapters. Separate reactions were done using 16S primers with and without incorporated 
internal index. Following PCR amplification, samples were purified and an additional 
PCR step was needed to add index sequences to the PCR product. Amplification was 
performed according to Illumina Nextera protocol to amplify tagmented DNA. Here 
after this protocol denoted as NX-tailed-2S. 
4.4.3 Pooling, purification and quantification 
Following PCR amplifications, libraries were pooled in equal volumes. Library pool 
was purified twice with Agencourt® AMPure® XP (Beckman Coulter, Brea, CA, USA) 
Quantification and quality control of DNA sample pool was analysed on Agilent 2100 
Bioanalyzer. 
4.4.4 Sequencing 
Sequencing of PCR amplicons was performed using the Illumina MiSeq (study I) and 
Illumina HiSeq 1500 (studies II & III) instrument (Illumina, Inc., San Diego, CA, USA). 
Samples from study I were sequenced as 251x 2 bp paired-end reads and  samples from 
the studies II & III with 271x 2 bp paired-end reads. DNA extracted from nine blank 
samples, two water samples and nine control saliva samples (in which 5 samples are 
replicates of sample 4c) using the above mentioned protocol and amplified with TS-
tailed 1S protocol without internal index, and sequencing performed (271 x 2 bp) using 
the Illumina HiSeq instrument.  
4.5 Bioinformatics analyses 
Sequencing quality, index trimming and length filtering was carried out and sequences 
were processed using MiSeq_SOP in mothur pipeline (Version v.1.35.1) (Schloss et al., 
2009) and sequences were aligned to ribosomal reference database arb-SILVA (Version 
V119) (Quast et al., 2012). High quality data was ensured for analysis by removing 
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sequence reads containing ambiguous bases, homopolymers > 8 bp, more than one 
mismatch in the primer sequence, less than 10 base pair assembly overlap, or less than 
default quality score in mothur. Assembled sequences with > 460 bp length, Chimeric 
sequences (Edgar et al., 2011) and singletons were removed from the analysis. The high-
quality assembled sequences were aligned to the SILVA 16S rRNA database and 
clustered into operational taxonomic units (OTUs) at a cut-off value > 98% sequence 
similarity. OTUs were classified using the SILVA bacteria taxonomy reference. OTU 
was normalized by subsampling to a threshold of 500 and 2000 in study II and II 
respectively. Alpha-diversity (Shannon and inverse Simpson index) was calculated per 
sample. Beta-diversity using the Bray Curtis dissimilarity indices was calculated 
between the samples/body size, and gender in the study I, and between AM groups in 
study III.  Sequencing depths were categorized into three groups: low <10,000, medium 
<100,000, high >100,000 sequences and used as a covariate in the statistical models in 
studies II & III. 
4.6 Statistical analyses 
In study I, the statistical analyses were conducted with R program (Version 3.4.1) for 
windows (//www.r-project.org/) and with SPSS (Version 22). Kruskal-Wallis (KW-test) 
test was performed on the alpha-diversity indices to evaluate the significant differences 
between the microbial diversity and the (TS-tailed and NX-tailed) methods used. 
Principal coordinate analysis (PCoA) plotted for beta-diversity was defined with Bray-
Curtis distance without normalizing the data using phyloseq R-package Ver 1.22.3 
(McMurdie and Holmes, 2014). Intraclass correlation coefficients (ICC) to measure the 
reproducibility, stability, and accuracy or neutrality of different protocol developed. Six 
metrics included relative abundances of four major phyla and two alpha-diversity 
indices used for ICC analysis.  
In study II, all statistical analyses were conducted with R program (Version 3.4.2) for 
windows. All participants were classified into four groups according to standard BMI 
cut-offs for children (Cole and Lobstein, 2012). KW-test was used to evaluate the 
significant difference in distribution of alpha-diversity measures across the body size 
groups, and gender. Interactions between gender and body size in the model were also 
examined. Differences in bacterial community structure between body size groups were 
tested using permutational analysis of variance (PERMANOVA) test with 999 
permutations in Phyloseq R-package. Differentially abundant bacteria were identified at 
the taxonomic levels of Order, Genus and OTUs using the zero-inflated Gaussian model 
(fitZig), implemented in the metagenomeSeq package-version 1.20.1 (Paulson, 2014; 
Paulson et al., 2013). Differences in bacterial abundance between a) normal weight vs. 
underweight, b) normal weight vs. overweight, c) normal weight vs. obese, d) normal 
weight vs. overweight + obese and e) boy vs. girl were tested. The analyses were 
adjusted for the sequence depth and gender, and the gender model was adjusted for 
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sequence depth only. P-values were calculated and adjusted by the false discovery rate 
(FDR).  
In study III, all statistical analyses were conducted with R (Version 3.4.2) using the 
stats4 (Version 3.4.2) vegan (version 2.5-4) and phyloseq (version 1.25.2) packages. 
Prescriptions of all AMs were grouped in to low ( 4), medium (5-13) and high ( 14) 
use. Similarly, the four most common AMs; Amoxicillin (< 1/2-5/>6), Azithromycin 
(0/1-3/>4), Amoxicillin and enzyme inhibitor (0/1-2 /> 3) and Phenoxymethylpenicillin 
(0/1/ >2) were also grouped to low, medium and high groups. AM prescriptions used as 
continuous variable in alpha-diversity and differential abundance analysis. Difference 
in the alpha-diversity was tested between age groups; gender with t-test, and between 
children’s languages; sequence depth groups with ANOVA using Shannon and inverse 
Simpson index. Difference in the microbial diversity between non-users and recent AM 
users (1-month, 2-month and 3-month use) were evaluated using the ANCOVA 
(adjusted for depth). Association of AM prescriptions with microbial diversity was 
evaluated using linear regression analysis. Prescriptions of all AM and the four most 
common AMs incorporated in the same model as continuous variable, and adjusted the 
analysis for gender, age, language and sequencing depth. This was performed for the all 
participants and separately for boys and girls.  
Permutational multivariate analysis of variance test (PERMANOVA) was performed on 
beta-diversity using the R-package vegan with 999 permutations. The analysis was 
adjusted for age, gender, language, other AMs and sequence depth. PERMANOVA 
performed between prescription groups of Low, Medium and High for all AM, and 
separately for the four most common AMs. Pairwise PERMANOVA was tested between 
prescription groups (Low-Medium, Low-High and Medium-High) and p-values 
adjusted with Benjamini-Hochberg method. Differentially abundant bacteria were 
identified at the OTU level using Negative Binomial GLM fitting and Wald statistics 
(nbinomWaldTest), implemented in the DESeq2 package (Love et al., 2014). AM 
prescriptions were used as continuous variable in the abundance analysis.  Differentially 
abundant OTUs at per unit change in the prescriptions of AMs were tested, i.e. a) all 
AMs, b) Amoxicillin, c) Azithromycin, d) Amoxicillin and enzyme inhibitor, and e) 
Phenoxymethylpenicillin. OTUs with low counts were filtered out (cut-off 20) in 
DESeq2 analysis. The analyses were adjusted for gender, age, language, other AMs and 
depth. The samples without sufficient background information and recent AM users 




Table 4: Summary of the methods used in the thesis. 
 Steps Method Study Reference  
Saliva DNA 
extraction  
Mechanical & chemical lysis I, II, III Yuan et al., 2012 
PCR amplification TS-tailed 1-step  I, II, III Study I 
TS-tailed 2-step  I Study I 
NX-tailed 1-step  I Study I 
Sequencing  MiSeq I   
HiSeq II, III   
Taxonomic 
classification 
Miseq_SOP in Mothur pipeline I,II, III Schloss et al., 
2009 





Kruskal-Wallis test I, II   
Intraclass correlation coefficients I   
t-test, ANOVA, ANCOVA, Linear 
regression 
III   
PERMANOVA II, III   
Differentially abundant bacteria 
(fitZIG, nbinomWaldTest) 





5.1 Reproducibility and repeatability of saliva microbiota profiles (I) 
A large-scale study of the saliva microbiota and body size relies on well-developed 
methodology, exploiting culture-independent NGS technologies. A challenge using 
NGS was to ensure high reproducibility and repeatability of the method. Thus, one of 
the study goals was to assess reproducibility and repeatability of saliva microbial 
profiling methods. 
The 16S rRNA amplicons on Illumina sequencing generated 598856 read pairs for 72 
samples (4 samples in triplicates x 6 methods) with TS-tailed and NX-tailed 
amplification, with and without internal index. Control samples (two water samples, 
nine saliva control samples including 5 replicates) and blank samples using TS-tailed 
1S protocol without internal index were sequenced on the Illumina HiSeq platform.  
 
Figure 9: The barplot shows the sequencing statistics of raw reads, passed quality check, and sequences 
aligned and classified (combined for methods used) in each method sequenced on the MiSeq platform. 
Samples sequenced using the TS-tailed 1S and 2S amplification protocols with and 
without internal index generated higher amounts of raw reads and sequences passed 
quality checks compared to the NX-tailed protocols (Figure 9). After the quality filtering 
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and index trimming, the sequences were clustered and assigned to 1086 OTUs. Among 
all the protocols, the percentage (>58%) of sequences classified in the TS-tailed and 
NX-tailed were higher in the protocol without internal index. The protocols with internal 
index showed a drop of 14-23 % OTUs for all the protocols.  
5.1.1 Microbial diversity among the protocols 
A similar pattern of Shannon diversity was observed in the individual’s samples 
sequenced with different protocols, except in those with low sequence depth (Figure 
10). Similar trend was marked with the inverse Simpson index for all the samples. 
Rarefaction analysis showed that an additional sequencing coverage was required for 
estimating the microbial richness in saliva, which was resolved by the HiSeq 
sequencing. 
No significant association (KW-test) was found between the alpha-diversity indices and 
the protocols used. Principle coordinate analysis (PCoA) using Bray-Curtis distance 
shows that irrespective of methods used, the samples clustered according to the 
individuals. The relative abundance of saliva microbiota at phylum level was measured. 
Five phyla were abundant in the samples: Actinobacteria, Bacteroidetes, Firmicutes, 
Fusobacteria and Proteobacteria. Similar patterns of microbial abundance were 
witnessed for the samples from the same individuals using the different protocols. 
5.1.2 Reproducibility and repeatability of the protocols  
Intra-class correlation coefficients (ICC) using six metrics included relative abundances 
of four top abundant phyla. Two alpha-diversity indices showed comparatively better 
reproducibility and stability with the TS-tailed 2S protocol with and without internal 
index.  
Repeatability of the TS-tailed 1S protocol was tested with nine control samples, two 
water samples and two blank samples sequenced in HiSeq Illumina platform. The result 
showed low diversity for the blank samples sequenced and high diversity for the control 
samples. Comparatively higher alpha-diversity observed for the five replicates of control 
sample 4 with high sequence depth than the MiSeq sequencing (Figure 11). Bacterial 
relative abundance of control samples at phylum level show high abundance of the phyla 





Figure 10: Alpha-diversity using Shannon (a) and Inverse Simpson (b) indices in four individuals’ 




Figure 11: Alpha-diversity using Shannon (a) and Inverse Simpson (b) indices for the participant 4 and 
its replicates sequenced with MiSeq using different amplification protocols and controls and 4c 
replicates in Hiseq platform using the TS-tailed-1S method.  
5.2 Comparison of the saliva microbiota between individuals with 
different body sizes (II) 
To compare the saliva microbiota between individuals of different body sizes, the 
participants were categorised into four groups according to age-specific BMI cut offs 
(Figure 12). Saliva microbial data came from 900 children sequenced with HiSeq 
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Illumina platform. The participants had a mean age of 11.9 years (S.D = 0.12). Among 
all, 73.3% of the participants were of normal weight. However, there was a higher 
proportion of underweight girls than boys (15.9% versus 11.5%) in this study. No 
significant gender differences in the proportion of overweight and obese children were 
observed.  
 
Figure 12: Distribution of the participants (n=900) according to their body size and gender (after 
removing individuals without metadata or consent or those with recent antimicrobial use). 
Approximately 133 million raw read pairs were generated from 16S amplicon 
sequencing. Rarefaction analysis showed that the sequencing approach and depth (mean 
148,508) was sufficient to determine the bacterial richness. On average 48248 
assembled sequences per sample were assigned to 6536 OTUs. A few OTUs were 
mostly assigned to negative control samples and sequences assigned that particular OTU 
was absent or negligible in Fin-HIT samples. 
5.2.1 Alpha- and beta-diversity 
No significant alpha-diversity observed between body sizes with all samples using the 
inverse Simpson index (Figure 13). Alpha-diversity differed significantly between 
genders. In addition, when the boys and girls were analysed separately, the alpha-
diversity of normal weight vs. overweight girls and normal weight vs. obese boys were 
different. There were statistically significant differences in the microbiota composition 
among body sizes with all samples, between genders and in gender separated analysis 




Figure 13: Alpha-diversity using Shannon (a) and inverse Simpson (b) indices for the all participants. 
5.2.2 Abundance of microbiota profiles 
Core saliva microbiota, i.e. bacteria present in more than 95% of the samples, consists 
of fourteen bacterial genera including Veillonella, Prevotella, Streptococcus, Neisseria, 
Selenomonas, Haemophilus, Eubacterium, Porphyromonas, Fusobacterium, Gemella, 
Campylobacter, Granulicatella, Leptotrichia and Johnsonella. The most abundant 
bacterial classes in the saliva were Clostridia (39.4%), Bacteroidia (19.3%), Bacilli 
(11.8%), Betaproteobacteria (7.5%), Gammaproteobacteria (7.4%), Actinobacteria 
(6.3%) and unclassified bacteria (4.3%) (Figure 14). No significant association of the 
ratio of Bacteroidetes to Firmicutes was observed to body size. Significant associations 
between the relative abundance of bacteria at different taxonomic levels and children’s 
body sizes, and among genders were found. A notable finding in the abundance analysis 





Figure 14: Stacked area plots show the abundant bacterial classes in children belonging to the four body size categories. Bars indicate relative 




5.3 The effects of antimicrobials (AM) on children’s saliva microbiota 
(III) 
There were 6168 AM treatments prescribed to participants from birth up to 3 months 
prior to the sampling/participation date. Amoxicillin (n=2698, 43.7%), Azithromycin 
(n=1542, 25%), Amoxicillin + enzyme inhibitor (n=1147, 18.6%) and 
Phenoxymethylpenicillin (n=424, 6.9 %) were the most commonly used AMs by the 
participants. An average use of 7.4 (SD=5.8) AMs per child. Average prescription was 
7.9 (S.D=6.0) and 6.9 (S.D=5.7) for any AMs in the boys and girls, respectively. 
5.4 Alpha- and beta-diversity 
No significant difference in the alpha-diversity was observed between recent AM 
prescriptions (= the use of AM less than 3 months prior to sampling) and those who are 
naïve (no prescriptions). No association was observed between prescriptions of all AMs 
and alpha-diversity using the Shannon index and Inverse Simpson index, as the violin 
plot shows alike diversity between AM prescription groups. Associations for the most 
common AMs prescriptions were tested and there was a significant association only for 
Azithromycin with Shannon diversity index.  
 
Figure 15: Violin plot shows the distribution of alpha-diversity as measured by a) Shannon and b) 
inverse Simpson indices for All AM prescription groups separated by gender in children. Triangles 




Figure 16: The violin plot shows the distribution of alpha-diversity as measured by a) Shannon and b) 
inverse Simpson indices for Azithromycin users separated by gender in children. Triangles inside the 
plots indicate the mean diversity in the group. 
In the gender-specific analysis, no association was observed for all AMs, similar result 
as in all children, with alpha-diversity in both genders (Figure 15). In girls, the 
association was significant for Azithromycin users as shown by Shannon index (Figure 
16). Microbial composition differed between the low, medium and high prescription 
groups for all AMs and in boys.  The microbial composition in Azithromycin users was 
significantly different in all children, boys, and partially in girls.  
5.4.1 Abundance of microbiota profiles 
Differentially abundant bacteria per AM prescription at OTU levels were tested. 
Bacterial taxa Paludibacter, Incertae sedis, Campylobacter, Streptococcus, 
Rikenellaceae, Prevotellaceae and Porphyromonas were differentially abundant in 






6.1 Microbiota profiling for large-scale epidemiological studies (I) 
The rising interest in the human microbiota and affordable technologies to quantify the 
microbiota profiles have encouraged researchers to improve the methods to overcome 
limitations inherent to the sequencing technologies. Several studies have been 
successfully used Illumina technology for 16S amplicon sequencing for diverse sample 
types (Bartram et al., 2011; Caporaso et al., 2012; Claesson et al., 2010; Degnan and 
Ochman, 2012; Fadrosh et al., 2014; Gloor et al., 2010; Kozich et al., 2013; Sinclair et 
al., 2015; Wu et al., 2018; Xun et al., 2018; Zhou et al., 2011). Through the course of 
the analyses presented in this study, six Illumina technology based TS-tailed and NX-
tailed amplification protocols were used on saliva samples with primers that were 
modified in-house (Klindworth et al., 2013; Yuan et al., 2012).  The primary aim of this 
study (I) was to simplify the amplification procedure for Illumina sequencing and to 
make use of barcodes efficiently to run large sample sets on the HiSeq platform. 
Saliva harbours numerous and diverse microorganisms shed from various intraoral 
surfaces. It has been shown that the oral cavity is colonized by 600-700 bacterial species 
(Chen et al., 2010; Dewhirst et al., 2010). The measured diversity depends on the method 
used for cellular disruption. Researchers have different opinions on the impact of DNA 
extraction methods on saliva microbiota profiles (Lazarevic et al., 2013a; Lim et al., 
2017).  Due to differences in the cell wall composition and structure, the bacterial cells 
may respond differently to lysis methods. The yield of bacterial diversity with different 
cell lysis methods, including chemical and mechanical (bead beating) lysis methods 
have been tested. Mechanical lysis methods give the highest bacterial diversity in 16S 
amplicon-based studies, especially when the microbial community comprises of gram-
positive bacteria, such as faecal samples (Robinson et al., 2016; Salonen et al., 2010; 
Santiago et al., 2014; Yuan et al., 2012). It has been reported that mechanical lysis 
(repeated bead-beating) yields greater bacterial diversity in saliva samples due to the 
rigid bacterial cell walls (Lazarevic et al., 2013a; Sohrabi et al., 2016). A study of mock 
communities, consisting of seven representative oral bacteria, showed that a method 
including bead beating was the only protocol which detected all seven species in the 
community (Abusleme et al., 2014). To reduce the bias that may arise due to the cell 
lysis step, all samples in the present study were lysed with a protocol including both 
enzymatic and mechanical disruption of microbial cells using bead beating. The storage 
and transportation conditions of samples may influence the DNA yields and qualities in 
microbiome studies (Goodrich et al., 2014a), but these do not have major impact on 
saliva microbiota (Lim et al., 2017; Nunes et al., 2012). 
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Four saliva samples in triplicates sequenced in MiSeq platform using different PCR 
amplification protocols provided higher sequencing depth for TS-tailed protocols and 
similar microbial diversity for all the protocols. It may be challenging to attain the 
satisfactory overlap of assembled paired-end sequences with the HiSeq platform. The 
current read length of 251x2 bp (rapid mode), the V3-V4 region of the 16S rRNA gene 
is a possible target for sequencing (Mizrahi-Man et al., 2013), however extending the 
read length to 271x2 bp on the HiSeq platform provided sufficient high quality overlap 
in the assembled reads.  
In MiSeq, though the data obtained with the NX-tailed protocol was low in sequence 
coverage, this protocol yielded high quality data and discarded a lower number of 
sequences than TS-tailed protocol (10% vs 18%, respectively). The protocols with 
internal indices provided a lower percent (<41%) of sequence data for the OTU 
classification, possibly due to insufficient overlap with additional indexes. Mismatching 
barcodes may cause loss of data in the microbiota sequencing (Degnan and Ochman, 
2012; Sinclair et al., 2015).  The indices in NGS have been introduced for multiplexing 
samples to add a large number of samples in one sequencing experiment (Goodrich et 
al., 2014a; Kozich et al., 2013). The advantage of error-correcting barcodes has been 
suggested for reducing the possibility of reads to assign to the wrong sample (Hamady 
et al., 2008). Repeated use of specific index sequences does not influence the amplicon 
yield (Goodrich et al., 2014a). A dual indexing protocol can increase the nucleotide 
diversity by adding random heterogeneity spacer at the start of sequencing reads 
(Fadrosh et al., 2014). A recent study modified the dual indexing strategy by adding a 
third Illumina compatible heterogeneous index with variable length to minimise the need 
for PhiX spike-in (de Muinck et al., 2017). The advantage of dual index with internal 
index enables sequencing of a large set of samples at low cost, and reduces the 
polymerase artefacts in high multiplex amplicon sequencing (Peng et al., 2015). 
The present study revealed that the numbers of phylotypes or OTUs yielded were 
comparatively similar in all the methods depending on the sequencing depth, and the 
rarefaction of the data suggested that bacterial diversity could be attained with higher 
sequence depth. The microbiota diversity was positively correlated with sequencing 
depth and was used as co-variable in the two other studies. The differences observed in 
the sequencing yield may be due to the protocol robustness. There are many reasons that 
might cause technical variability detected in the microbiota studies; like laboratory 
protocol, sequencing platform and bioinformatics approach  (Salter et al., 2014; Sinha 
et al., 2015).  Nevertheless, in the present study all protocols delivered comparatively 
similar microbiota profile for the saliva triplicates. Technical challenges may arise in 
16S rRNA amplicon sequencing due to the PCR primer selection, PCR template 
concentration and amplification conditions and sequencing. The importance of 
investigating technical replicates to validate the reproducibility of microbiota methods 
has been discussed recently (Wen et al., 2017). The average alpha-diversity for the four 
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samples from different protocols provided comparatively similar diversity with the 
exception of samples with low amount of sequences. With the mixed-effect model–
based Intra Correlation Coefficient analysis (Sinha et al., 2016), sequencing protocols 
using TS-tailed 2S protocol with and without internal index performed better than the 
other protocols tested. 
The repeatability of the TS-tailed 1S method without internal index was tested on HiSeq 
platform. Nine samples sequenced on HiSeq yielded high sequence depth (48K-398K) 
reads. The reproducibility can be increased by increasing sequencing depth. Our samples 
had comparatively high alpha-diversity for the data produced with HiSeq sequencing 
and low variation among them. Alpha-diversity was similar for the sample 4 sequenced 
on both MiSeq with different protocols and HiSeq platform with the TS-tailed 1S 
protocol. The major limitation of this study is the small number of samples for testing 
in each method, however, the number of samples and the sequencing depth was seen 
sufficient to recommend the method that should or should not be used in large-scale 
microbiota studies.   
6.2 Comparison of saliva microbiota in children with different BMI (II) 
The purpose of this large-scale study was to characterize the saliva microbiota in a 
population of children with different BMI, which had not been explored previously. 
Different saliva microbiota indices and profiles in underweight, overweight, obese and 
all overweight (+obese) was compared to normal weight children. To our knowledge, 
this study with 900 participants is the first large-scale study that explores the association 
of the saliva microbiota and body sizes in children. The sample size (483 girls and 417 
boys) ensured statistical power to detect differences in microbiota between body sizes, 
and genders. The amplicon methods (TS-tailed 1S without internal index) used ensured 
large amount of sequence data (mean 148,508 read pairs). 
The microbiota assists the host in resisting invasion of pathogens, and its biodiversity is 
known to be associated with health. It has been suggested that gut microbiota 
composition in early life predicts weight development in later childhood, and disruption 
of the original microbiota may have health consequences in later stages of life (Korpela 
et al., 2016). A decreased gut microbiota diversity has been linked to obesity (Turnbaugh 
et al., 2009)  and many systemic and non-systemic diseases (Wang et al., 2017). Similar 
associations between altered oral microbiota and health have also been reported 
(Acharya et al., 2017a; Belstrom et al., 2016; Xun et al., 2018). A recent study in adults 
showed that obese groups have distinct saliva microbiota profiles compared to normal 
weight adults (Wu et al., 2018).  In the present study, the saliva microbiota was 
associated with children’s BMI. The differences observed in the saliva microbiota were 
gender-specific, indicating the microbiota-body size association differs between boys 
and girls. The finding is in line with the gut microbiota where distinctive bacteria were 
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associated with men and women which may be inclined by the severity of obesity (Haro 
et al., 2016). The gender differences in the present study may be induced by endocrine 
and hormonal factors (Zaura and Ten Cate, 2015) as the participants are about to enter 
puberty. Beta-diversity analysis suggests that the bacterial composition in saliva was 
significantly different between the normal weight and obese participants, but in girls 
only. Significant gender-differences in bacterial composition were also observed. The 
differences in the alpha-diversity between body sizes and gender were also reflected in 
the beta-diversity analysis. A study on the upper digestive tract microbiome of adults 
showed that beta-diversity was associated with a four-fold difference in obesity (Lin et 
al., 2015).  
Among the present cohort, microbial abundance differed between underweight, normal 
weight, overweight and obese children. A key finding was a many-fold decrease in the 
relative abundance of core saliva bacteria in children of all body sizes. The genus 
Prevotella associated with BMI may potentially be a novel marker in saliva to identify 
the children at risk of gaining excess weight. To support this hypothesis, a study on gut 
microbiome of adolescents (aged 13-16 year) has shown that Bacteroides and Prevotella 
were associated with BMI and positively correlated with triglycerides, total cholesterol, 
and high-sensitive C-reactive protein (Hu et al., 2015). However, the BMI-associated 
bacteria of saliva in this study were different from those found in the gut (Human 
Microbiome Project Consortium et al., 2012; John and Mullin, 2016), confirming the 
differences between saliva and gut microbiota diversity and composition in different 
obesity states. Firmicutes, Bacteroidetes, Proteobacteria, Actinobacteria, Candidate 
division TM7, and Fusobacteria were the six dominant (>3%) phyla in the saliva of 
children, and these findings are in line with earlier studies (Lazarevic et al., 2012). The 
abundant bacterial taxa in the children’s saliva were Veillonella, Prevotella, 
Streptococcus, Selenomonas, Neisseria, Haemophilus, Micrococcineae, Gemella, and 
Neisseria. Individual genetics and lifestyle, geography, and variations in the lysis 
procedure and PCR amplification may be the reason of differences in the taxa 
abundances (Lazarevic et al., 2011).  
The strengths of the present study include a large sample size and a homogeneous age-
group of children who do not normally suffer from periodontitis and other chronic 
diseases (Alabdulkarim et al., 2005; Sarlati et al., 2008). The limitation of this study is 
the lack of oral health status, eating habits and pubertal status of the children, which are 
potential confounders. In Finland, public oral health care services are freely accessible 
to children under 18 years, most of the children and adolescents have good oral health 
and declining trends in caries occurrence rate has been seen (Mattila et al., 2016). Other 
factors that may influence the results such as dieting, smoking and alcohol consumption 
are unlikely in this age group. However, these findings from children may not be 
generalizable to adults and elderly populations. As a part of the educational system in 
Finland, children receive healthy lunches and snacks at school, for which we assume 
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that a major part of the participants’ diet is similar and did not take into account the 
potential dietary confounding in this study. An on-going study have not identified 
associations between eating habits and saliva microbiota in this cohort (personal 
communication Viljakainen et al), supporting this assumption. The recently developed 
molecular methods help researchers to expand the knowledge of the composition and 
function of the oral microbiota in health and disease (Gao et al., 2018). It has been shown 
that the saliva microbiota is more resilient and stable despite the changes in diet and oral 
hygiene (Stahringer et al., 2012). Thus, the saliva-based health monitoring using 
microbial biomarkers may be considered a feasible, simple, easy to collect with high 
compliance for all age groups and economical alternative compared to faecal samples.  
6.3 The effects of lifetime antimicrobials on children’s saliva microbiota 
(III) 
The purpose of the study was to describe the association between saliva microbiota and 
lifetime use of antimicrobials in children, which has not been explored previously. 
Saliva microbiota diversity indices and profiles were analysed in AM users and non-
users. The microbiota diversity in the Azithromycin user groups differed in a gender-
specific way and was more profound in girls than boys. The findings are in line with a 
saliva microbiota study where diversity and composition were altered by short-term 
azithromycin use (Cabral et al., 2017). Association between saliva microbiota and recent 
AM use within three months prior to sampling was not identified. Hence, AM use in 
recent years might not influence the saliva microbiota in children in the long-term. The 
salivary community seems to be more stable and resilient and less susceptible to 
dysbiosis resulting from of recent antimicrobial perturbations, but longitudinal studies 
are needed from the infancy to the adulthood to study the long-term resilience, stability 
and consequences.  
The microbial composition was significantly different between all AMs combined user 
groups and in Amoxicillin and Azithromycin in all children, and separately in boys. The 
results are in line with a recent study investigating children’s gut microbiota, in which 
it was reported that macrolides impact the microbiota composition (Korpela et al., 2016). 
AMs are commonly used drugs to treat the bacterial infections, which ultimately result 
in the reduction of pathogenic and commensal bacteria in humans and animals (Zaffiri 
et al., 2012). The immediate effect of AMs on the gut microbiota is higher than any other 
factors (Dethlefsen and Relman, 2011; Modi et al., 2014). AM use in childhood is 
associated with noticeable changes in the gut microbiota composition, which persist for 
over six months (Korpela et al., 2016).  Also, a short-term effect of AMs has been found 
on the saliva microbiota (Abeles et al., 2015; Zaura et al., 2015). Paediatric populations 
are commonly exposed to infections and AM use which can disrupt the natural 
microbiome from very early stage of life (Taggart and Bergstrom, 2014; Virta, 2012). 
No significant difference in the association of the saliva microbiota and lifetime AM use 
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was observed in the sensitivity analysis, after excluding the AM use in the first three 
years in the participants early life.  
The present study did not investigate the disruption and re-establishments of microbiota 
with the effect of one single treatment, but the effect of several repeated treatments.  An 
increased use of AM puts humans at increased risk for being a carrier of antibiotic-
resistant bacteria (Costelloe et al., 2010). The majority of studies on antibiotics are 
performed in adults, or have analysed short-term effects on the microbiota of children. 
Up to date, the present study is the first to explore the effect of lifetime (~ 12 year) AM 
use on the saliva microbiota. The strength of the study includes validated national 
registers. The register keeps the records of not only the use of the drug, but also the 
antimicrobial drug purchases which is a strong indicator of AM intake. The diagnoses 
were not recorded in the drug purchase register; however, similar pattern of AM use 
have been observed in boys and girls.  
Men and women differ in their microbiome composition (Levy and Solt, 2018). Study 
on the characteristics of gender-specific microbiome was first reported in 2011 (De 
Cárcer et al., 2011). Flak et al coined the term ‘microgenderome’ in 2013 which refers 
to the interaction between microbiota, sex hormones and immune system (Markle et al., 
2013). The gender-specific saliva microbiome and metabolome profiles have been 
associated with salivary pH and dietary protein intake (Zaura et al., 2017). Some of these 
differences observed between genders are consequences of hormones. Twin studies 
demonstrated that the microbial composition of opposite sex twins differed when they 
attained puberty compared to same sex twins (Wallis et al.; Yatsunenko et al., 2012). 
The gender-specific fat distribution associated with the differences in sex hormone 
levels (Haro et al., 2016). There is a gender-specific association between the early 
antibiotic exposure and body size development (Ajslev et al., 2011). The biological 
explanation for this gender specificity remains unexplored, but could be related to 
microbiota–host interactions (García-Gómez et al., 2013; Markle et al., 2013). 
As shown in study II, there is an association between the saliva microbiota and body 
size in children. The use of antimicrobials, especially macrolides, in early life was 
positively correlated between overall lifetime antibiotic use and BMI, as well as an 
increased risk of asthma later in childhood (Korpela et al., 2016).  Antibiotics have been 
linked to gut microbiota dysbiosis, which may lead to obesity, however, the mechanisms 
through which AMs modulate the weight development is unclear (Leong et al., 2018). 
Several hypotheses have been proposed: altered energy extraction from indigestible 
polysaccharides; an altered number of bacteria that are metabolically protective against 
obesity, metabolic signalling, hepatic lipogenesis, and intestinal defence and immunity 
(Leong et al., 2018). A similar human microbiota study has been reported the gender-
dependent gut microbiota in relation to BMI (Kim et al., 2019). The factors affecting the 
gender differences in gut microbiota may be due to the interaction with sex hormones. 
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Alpha-diversity differed significantly between males and females after puberty 
(Yurkovetskiy et al., 2013). In the present study, the participants were children of 11.7 
years of age (mean), and some participants might have reached puberty. Findings in the 
present study suggest that young children might be vulnerable to weight gain due to 
extensive use of AMs. The frequent use of AMs cause rise in antibiotic-resistant bacteria 




7. CONCLUSIONS AND FUTURE PROSPECTS 
Large-scale epidemiological studies on microbiota are feasible with the recent 
advancements in the NGS technologies and culture-independent molecular techniques. 
The challenge in obtaining reproducible microbiota profiles using NGS was addressed 
in this thesis. All the different indexing schemes tested produced microbiota profiles 
with high reproducibility. The TS-tailed-1S dual index protocol was preferred and used 
in the other two studies of this thesis since it delivers reproducible and repeatable 
profiles on the HiSeq platform and is economic and less labour intensive.  
The thesis shows that saliva microbiota is associated with BMI and lifetime 
antimicrobial use and is gender-specific. The prominent finding of this study was the 
many fold decrease in the core commensal saliva bacteria in overweight and obese 
children compared to normal weighted children. The BMI and gender-specific saliva 
microbiota profiles open new possibilities to study the potential roles of microbiota in 
weight management. In addition, there is concern over the consequences of high lifetime 
AM use, which substantially decrease bacterial richness and composition in children. 
The use of azithromycin had a significant effect on the saliva microbiota.  The exposure 
to antimicrobials in the first decade of life may cause the disruption of natural 
microbiota, which may have long-term health consequences in later stages of life. Thus, 
emphasizing the importance of microbiota in developing new therapeutic strategies at 
early life and childhood and, to sensibly limit the use of AMs. Saliva microbiota was 
associated with BMI and antimicrobials and it was gender dependent. The gender 
specific saliva microbiota profiles may be due the children’s pubertal stage, where 
diversity differs after the puberty in humans.  
Saliva microbiota is more resilient than gut microbiota when exposed to antibiotics and 
stable for several years even when changes in diet and oral hygiene occur. Thus, the 
saliva-based screening of microbial biomarkers, in health surveillance and the 
associations with oral and general health status may be considered a feasible, simple, 
easy to collect with high compliance for all age groups and economical alternative. 
However, further research on the metabolic and functional potentials of the saliva 
microbiota is needed to fully understand the saliva microbiota – host relationship. The 
rise in AM use and increased antimicrobial resistance (AMR) is a major threat to human. 
To effectively tackle this problem, whole microbiota needs to be investigated to discover 
the range of different AM resistant genes in bacteria. With metagenomics sequencing, 
we can explore the functional details of bacteria in saliva and antibiotic resistance genes 
in bacteria.  Because most of the bacteria are uncultivable in the laboratory, 
metagenomics approaches need to be used to explore the functional potential of saliva 
microbiota. It also helps to explore the mobile genetic elements that cause the spreading 




Ihmisen iholla ja limakalvoilla elävä normaalimikrobisto auttaa ylläpitämään terveyttä 
ja torjumaan sairauksia. Elämäntapatekijät, kuten ruokavalio ja fyysinen aktiivisuus 
sekä ympäristö ja altistus antibiooteille todennäköisesti muokkaavat bakteeristoa 
keskeisellä tavalla. Suolistobakteerit näyttävät olevan yhteydessä ylipainoon ja 
lihavuuteen, mutta syljen bakteeriston ja painoindeksin (BMI) välisiä yhteyksiä on vielä 
toistaiseksi tutkittu niukasti. Lihavuus on maailmanlaajuinen epidemia, ja vuonna 2016 
ylipainoisia ja lihavia oli jo 1,9 miljardia. Lapsuudenaikainen ylipaino ja lihavuus 
todennäköisesti jatkuu aikuisuuteen ja on yhteydessä suurentuneeseen sairausriskiin 
varhaisemmalla iällä. Siksi bakteerien ja painon välinen yhteys on tärkeää selvittää.  
Antibioottien käyttö ja samalla antibioottiresistenssi on lisääntynyt. Resistenssi johtaa 
siihen, että monen sairauden hoitomahdollisuudet kutistuvat. Altistuminen antimikrobi-
lääkkeille (AM-lääkkeet) vaikuttaa suoliston bakteeriston monimuotoisuuteen ja 
koostumukseen, mutta niiden vaikutuksista syljen bakteeristoon tiedetään toistaiseksi 
vähän. Lapset käyttävät AM-lääkkeitä usein, joten syljen bakteeriston ja käytön välisiä 
yhteyksiä on tärkeää tutkia. Tämän väitöskirjan tavoite oli kehittää kustannustehokas 
menetelmä, jolla syljen bakteeristoprofiili voidaan määrittää laajoissa väestöaineis-
toissa, sekä lisäksi käyttää tätä uutta menetelmää syljen bakteeriston ja painon sekä 
elinaikaisen AM-lääkkeiden käytön välisten yhteyksien määrittämiseksi lapsilla. 
Tulokset osoittivat, että kaikkien testattujen 16S rRNA -geenin monistukseen ja 
sekvensointiin käytettyjen menetelmien tuottamat syljen bakteeristoprofiilit olivat 
keskenään samankaltaisia, ts. mikään menetelmistä ei ollut selvästi muita parempi. 
Syljen bakteeristoprofiilit olivat sukupuolelle ominaisia alfa- ja betadiversiteetin sekä 
tiettyjen bakteerien suhteellisen runsauden suhteen. Merkittävä löydös oli ylipainoisilla 
ja lihavilla lapsilla näkynyt ydinbakteeriston väheneminen. Elinaikaisen AM-
lääkealtistuksen ja syljen bakteeriston analyysi osoitti, että atsitromysiinin käyttö oli 
yhteydessä alentuneeseen alfadiversiteettiin kaikilla lapsilla sekä erikseen tytöillä. 
Syljen bakteeriston koostumus erosi merkitsevästi matalan, keskitason ja korkean AM-
lääkkeiden käytön ryhmien välillä kaikilla lapsilla. Tarkasteltaessa eri antibiootteja 
erikseen atsitromysiinin käytön suhteen löydettiin samanlainen suuntaus, mutta 
amoksisilliinin kohdalla bakteeriston koostumus erosi merkitsevästi ainoastaan pojilla.  
Tämä väitöskirjatyö esittää, että syljen bakteeristo on merkitsevästi yhteydessä painoon, 
AM-lääkkeiden käyttöön ja sukupuoleen suomalaislapsilla. Syljen bakteeriston 
profiloinnilla on mahdollista kehittää uusia tapoja tutkia bakteerien mahdollista roolia 
lasten painonkehityksessä. Vaikutukset normaalibakteeristoon tulisi ottaa huomioon 
myös kehitettäessä uusia hoitomenetelmiä, jotta AM-lääkkeiden käyttöä saataisiin 
rajoitettua. Aiemmat tutkimukset ovat osoittaneet, että syljen bakteeristo on 
vastustuskykyisempi ja vakaampi antibiootteja vastaan kuin suoliston bakteeristo, joten 
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mikrobimarkkereiden seulonta syljestä ulostenäytteen sijaan on helppo, taloudellinen ja 
kaikille ikäryhmille soveltuva vaihtoehto käytettäväksi terveydenhuollossa. Bakteeris-
ton metabolisia ja toiminnallisia piirteitä on kuitenkin tutkittava lisää, jotta syljen 
bakteerien ja isännän välisiä vuorovaikutuksia ja niiden merkitystä terveydelle voidaan 
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